@article{97bf370dfb61421587aff4737ee59813,
title = "Some numbers behind Canada's decision to adopt an orphan drug policy: US orphan drug approvals in Canada, 1997-2012",
author = "Matthew Herder and Krahn, {Timothy Mark}",
note = "Funding Information: This research was supported by grant funding from Genome Canada as part of a larger research project called {"}IGNITE.{"} Some support was also received through the Canada Research Chair in Bioethics and Philosophy on {"}Impact Ethics: Making a Difference{"} (http://bit.ly/ X6YKO2) awarded to Fran{\c c}oise Baylis. Without the research assistance of Katrina Grentz, this research would not have been possible. The authors would also like to thank members of the Novel Tech Ethics research group at Dalhousie University for their feedback on a draft of this paper. The authors declare that they have no competing or conflicting interests. Publisher Copyright: {\textcopyright} 2016, Longwoods Publishing Corp. All rights reserved.",
year = "2016",
doi = "10.12927/hcpol.2016.24626",
language = "English",
volume = "11",
pages = "70--81",
journal = "Healthcare Policy",
issn = "1715-6572",
publisher = "Longwoods Publishing Corp.",
number = "4",
}
